🌎 3M Upgraded, Novavax Downgraded, Sprouts Farmers Market Upgraded and more...

Ratings changes for CrowdStrike, Symbotic, Adaptimmune Therapeutics, Encore Wire, Novavax, Sprouts Farmers Market, Amkor Technology and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More. Unsubscribe. VIEW MY PORTFOLIO July 30th, 2024     This CEO sold his first company to Microsoft. Now he's quietly building a new AI company that the tech giant is already eyeing. (ad) Microsoft did their due diligence...and they say this AI company's tech is meeting even their incredibly high bar. Find out who Microsoft has now vetted. Today's Top Stories This Semiconductor Stock Is ON Track for a New High American consumers feeling more confident in July as expectations of future improve Kiss of death for Democrats (Porter & Company) Why SoFi Stock is an Unmissable Growth Opportunity U.S. job openings fall slightly to 8.2 million as high interest rates continue to cool labor market Has Micron's Stock Drop Turned Into A Screaming Buy? Ethiopia's currency dives by 30% as IMF-backed reforms to stabilize the economy take effect Musk's new company could top a trillion? (Paradigm Press) Should You Invest in Bonds? Here's What to Know China's top leaders vow to support consumers and improve confidence in its slowing economy Why This Manufacturer is Committing to a Massive Buyback Program Europe's growth lags US again, as Germany remains the eurozone's economic problem child Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings The #1 Crypto for AI (ad) We've issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it's too late. It's urgent because it's what we consider "The #1 Crypto for the AI World." Learn more about it by watching THIS NOW. Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades Affirm (NASDAQ:AFRM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $36.00 price target on the stock. This represents a 26.4% upside from the current price of $28.47. AON (NYSE:AON) was upgraded by analysts at Keefe, Bruyette & Woods from an "underperform" rating to an "outperform" rating. They now have a $380.00 price target on the stock, up previously from $313.00. This represents a 16.1% upside from the current price of $327.22. ASML (NASDAQ:ASML) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.The current price is $888.45. BrightView (NYSE:BV) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $17.00 price target on the stock, up previously from $13.00. This represents a 21.7% upside from the current price of $13.97. Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $47.00 price target on the stock. This represents a 24.5% upside from the current price of $37.74. LPL Financial (NASDAQ:LPLA) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $268.00 price target on the stock. This represents a 20.6% upside from the current price of $222.23. 3M (NYSE:MMM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $145.00 price target on the stock. This represents a 16.3% upside from the current price of $124.66. RTX (NYSE:RTX) was upgraded by analysts at Alembic Global Advisors from a "neutral" rating to an "overweight" rating. They now have a $134.00 price target on the stock. This represents a 15.7% upside from the current price of $115.80. Sprouts Farmers Market (NASDAQ:SFM) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $90.00 price target on the stock, up previously from $62.00. This represents a 8.9% downside from the current price of $98.76. Sprouts Farmers Market (NASDAQ:SFM) was upgraded by analysts at BMO Capital Markets from an "underperform" rating to a "market perform" rating. They now have a $102.00 price target on the stock, up previously from $40.00. This represents a 3.3% upside from the current price of $98.76. Varonis Systems (NASDAQ:VRNS) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $60.00 price target on the stock, up previously from $52.00. This represents a 10.2% upside from the current price of $54.44. View today's most recent analysts' upgrades at MarketBeat.com Historic NVIDIA partnership could send this tiny AI stock soaring... (ad) After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>> Analysts' Downgrades Abbott Laboratories (NYSE:ABT) was downgraded by analysts at Edward Jones from a "buy" rating to a "hold" rating.The current price is $104.15. Bank of Montreal (NYSE:BMO) (TSE:BMO) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.The current price is $83.98. Cognition Therapeutics (NASDAQ:CGTX) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.The current price is $1.15. Criteo (NASDAQ:CRTO) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $43.70. Centuri (NYSE:CTRI) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $17.00 price target on the stock, down previously from $30.00. This represents a 9.7% upside from the current price of $15.50. Flushing Financial (NASDAQ:FFIC) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $16.50 price target on the stock, up previously from $15.00. This represents a 9.5% upside from the current price of $15.07. Gentex (NASDAQ:GNTX) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $34.00 price target on the stock. This represents a 8.1% upside from the current price of $31.45. Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $16.00 price target on the stock, down previously from $17.00. This represents a 9.8% downside from the current price of $17.73. Integra LifeSciences (NASDAQ:IART) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $23.00 price target on the stock, down previously from $30.00. This represents a 10.2% downside from the current price of $25.61. Integra LifeSciences (NASDAQ:IART) was downgraded by analysts at BTIG Research from a "neutral" rating to a "sell" rating. They now have a $22.00 price target on the stock. This represents a 14.1% downside from the current price of $25.61. Lattice Semiconductor (NASDAQ:LSCC) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $47.00 price target on the stock, down previously from $83.00. This represents a 7.2% downside from the current price of $50.64. Merchants Bancorp (NASDAQ:MBIN) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $58.00 price target on the stock, up previously from $55.00. This represents a 29.2% upside from the current price of $44.89. Novavax (NASDAQ:NVAX) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $8.00 price target on the stock. This represents a 37.4% downside from the current price of $12.78. Sage Therapeutics (NASDAQ:SAGE) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $10.00 price target on the stock, down previously from $16.00. This represents a 6.2% downside from the current price of $10.66. Shore Bancshares (NASDAQ:SHBI) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating.The current price is $14.54. Silicom (NASDAQ:SILC) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $13.12. Frontier Group (NASDAQ:ULCC) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.The current price is $4.09. View today's most recent analysts' downgrades at MarketBeat.com SHOCKING Crypto Leak… (ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Analysts' New Coverage Adaptimmune Therapeutics (NASDAQ:ADAP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $4.00 price target on the stock. This represents a 172.1% upside from the current price of $1.47. Corbus Pharmaceuticals (NASDAQ:CRBP) is now covered by analysts at Wedbush. They set an "outperform" rating and a $85.00 price target on the stock. This represents a 43.1% upside from the current price of $59.41. Gryphon Digital Mining (NASDAQ:GRYP) is now covered by analysts at HC Wainwright. They set a "neutral" rating on the stock.The current price is $0.94. Ligand Pharmaceuticals (NASDAQ:LGND) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $130.00 price target on the stock. This represents a 18.7% upside from the current price of $109.56. Movano (NASDAQ:MOVE) is now covered by analysts at Benchmark Co.. They set a "speculative buy" rating and a $2.00 price target on the stock. This represents a 404.0% upside from the current price of $0.40. Whirlpool (NYSE:WHR) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $88.00 price target on the stock. This represents a 11.6% downside from the current price of $99.52. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: hidden income trade in Apple? (Click to Opt-in)